Live feed
Filing
SC 13G
SC 13G0001193125-18-281390·NAVIDEA BIOPHARMACEUTICALS, INC.
Schedule 13G ownership disclosure
NAVIDEA BIOPHARMACEUTICALS, INC.
Security class unavailable · CUSIP: 63937X103
Event date: 2018-09-13
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 12.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-18-281390
- Form type
- SC 13G
- Filer
- NAVIDEA BIOPHARMACEUTICALS, INC.
- CIK
- CIK 810509
- Filed
- Sep 24, 2018
- Reporting period
- Sep 13, 2018
- Description
- Schedule 13G beneficial ownership